Philadelphia Trust CO Gilead Sciences, Inc. Transaction History

Philadelphia Trust CO

$1.38 Billion
Q3 2024

A detailed history of Philadelphia Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Philadelphia Trust CO holds 86,182 shares of GILD stock, worth $7.77 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

86,182

Previous 76,617 12.48%

Holding current value

$7.77 Million

Previous $5.26 Million 37.44%

% of portfolio

0.52%

Previous 0.41%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $636,933 - $803,364	9,565 Added 12.48%	86,182 $7.23 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $421,399 - $486,328	-6,673 Reduced 8.01%	76,617 $5.26 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $39,440 - $48,096	-551 Reduced 0.66%	83,290 $6.1 Million
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $102,578 - $116,326	-1,400 Reduced 1.64%	83,841 $6.79 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $61,444 - $67,036	831 Added 0.98%	85,241 $6.39 Million
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $188,884 - $215,449	-2,485 Reduced 2.86%	84,410 $6.51 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $403,944 - $460,218	-5,225 Reduced 5.67%	86,895 $7.21 Million
Q4 2022 Feb 07, 2023	SELL	$62.32 - $89.47 $823,247 - $1.18 Million	-13,210 Reduced 12.54%	92,120 $7.91 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $343,843 - $392,757	-5,775 Reduced 5.2%	105,330 $6.5 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $43,578 - $49,082	-755 Reduced 0.67%	111,105 $6.87 Million
Q1 2022 May 05, 2022	BUY	$57.92 - $72.58 $2.66 Million - $3.33 Million	45,845 Added 69.45%	111,860 $6.65 Million
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $59,365 - $67,380	915 Added 1.41%	66,015 $4.79 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $3.39 Million - $3.66 Million	50,050 Added 332.56%	65,100 $4.55 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $92,856 - $101,459	-1,463 Reduced 8.86%	15,050 $1.04 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $6,600 - $7,530	-110 Reduced 0.66%	16,513 $1.07 Million
Q4 2020 Feb 08, 2021	BUY	$56.65 - $64.55 $2,379 - $2,711	42 Added 0.25%	16,623 $968,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $26,889 - $33,808	-433 Reduced 2.54%	16,581 $1.05 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $18,953 - $22,008	262 Added 1.56%	17,014 $1.31 Million
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $144,675 - $185,308	-2,310 Reduced 12.12%	16,752 $1.25 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $206,735 - $227,401	-3,355 Reduced 14.97%	19,062 $1.24 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $132,833 - $146,625	-2,125 Reduced 8.66%	22,417 $1.42 Million
Q2 2019 Aug 08, 2019	SELL	$61.87 - $69.38 $38,978 - $43,709	-630 Reduced 2.5%	24,542 $1.66 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $78,912 - $88,403	1,262 Added 5.28%	25,172 $1.64 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $10,594 - $13,825	175 Added 0.74%	23,910 $1.5 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $15,681 - $17,362	220 Added 0.94%	23,735 $1.83 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $85,641 - $99,897	-1,320 Reduced 5.32%	23,515 $1.67 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $207,958 - $253,524	2,855 Added 12.99%	24,835 $1.87 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $192,745 - $226,255	2,709 Added 14.06%	21,980 $1.58 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $1.39 Million - $1.65 Million	19,271	19,271 $1.56 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Account

Philadelphia Trust CO Gilead Sciences, Inc. Transaction History